| Metric | Q2 FY27 | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue from operations | 0.0 | 0.0 | 0.1 |
| Total income | 0.0 | 0.0 | 0.1 |
| Profit before exceptional items & tax | -0.0 | 0.0 | 0.0 |
| Profit before tax | -0.0 | 0.0 | 0.0 |
| Net profit | -0.0 | 0.0 | 0.0 |
| Operating margin | 0.0% | 38.5% | 3.7% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
BSE results filing, NSE: GVBL. Figures extracted from the filing.
Genomic Valley Biotech Ltd: key numbers
- Share price
- ₹53.02
- Market cap
- ₹16.19 Cr
- Revenue (annual)
- ₹0.27 Cr
- Net profit (annual)
- ₹0.03 Cr
- P/E (TTM)
- -5865.0×Sector 41.3×
- Promoter holding
- 46.06%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Genomic Valley Biotech Ltd
All →Genomic Valley Biotech Open Offer: ₹2.38 Cr
Fintellectual Corporate Advisors filed the Draft Letter of Offer for an open offer by Pankaj Grover and Abhisek Gupta. They seek 7,94,170 shares (26%) of Genomic Valley Biotech at ₹30 per share.
- Value
- ₹2.38 Cr
Genomic Valley Biotech Open Offer: ₹57.97 Cr
Manager to the Open Offer filed GVB's DPS announcing an open offer for up to 7,94,170 shares at ₹730. The Acquirers seek about 21% of the company.
- Value
- ₹57.97 Cr
Genomic Valley Biotech Board Meeting Date
Board meeting scheduled for October 30, 2026, to consider unaudited Q2 and H1 FY27 financial results. Trading window closed pending results publication.
Genomic Valley Biotech Merger & Restructuring
Promoter Yogesh Agrawal has entered into a Share Purchase Agreement to sell his entire 46.06% stake in Genomic Valley Biotech to Pankaj Grover and Abhisek Gupta.
Genomic Valley Biotech Open Offer: ₹2.38 Cr
Acquirers Pankaj Grover and Abhisek Gupta announced an open offer for 7.94 lakh shares of Genomic Valley Biotech Ltd at ₹30 per share.
- Value
- ₹2.38 Cr
Genomic Valley Biotech Other Announcement
Genomic Valley Biotech Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026. This mandatory disclosure provides details on the company's shareholding structure.